Department of Health
and Human Services (HHS)
and Human Services (HHS)
August 3, 2021
PAR-21-267 - NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
National Institute of Neurological Disorders and Stroke (NINDS)
The purpose of this notice is to inform applicants of a correction to the open date for PAR-21-267 "NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)". This Funding Opportunity Announcement (FOA) has been changed to show that first standard due date for this FOA is September 5, 2021. Changes to the FOA are shown below.
Currently Reads:
Part 1. Overview Information
Key Dates:
| Application Due Dates: |
Standard dates apply The first standard due date for this FOA is September 7, 2021. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
Modified to Read:
Part 1. Overview Information
Key Dates:
| Application Due Dates: |
Standard dates apply The first standard due date for this FOA is September 5, 2021. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
All other aspects of this FOA remain unchanged.
Emily Caporello, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1778
Email: [email protected]